Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Frucht
David M. Frucht, Vienna, VA US
| Patent application number | Description | Published |
|---|---|---|
| 20100227349 | USE OF LYMPHOCYTES TO MEASURE ANTHRAX LETHAL TOXIN ACTIVITY - It is disclosed herein that isolated lymphocytes, such as human B-cells and CD4 | 09-09-2010 |
Johannes Frucht, Soest-Ampen DE
| Patent application number | Description | Published |
|---|---|---|
| 20090309518 | APPARATUS AND METHOD FOR MONITORING AT LEAST ONE FLUORESCENT LAMP - An apparatus for monitoring at least one fluorescent lamp, in particular in an explosion-hazard area, which fluorescent lamp has a lamp tube with electrodes arranged at its ends in the form of filaments, and has a ballast, is improved in order to avoid an excessive temperature increase while maintaining the appropriate explosion protection in that the monitoring apparatus has at least one temperature measurement device, associated with a filament, and an electronic interruption device, by means of which interruption device the power supply can be interrupted by means of the ballast on reaching a predetermined critical temperature. The invention likewise relates to a corresponding method for monitoring at least one fluorescent lamp, in particular in an explosion-hazard area. In this method, the temperature is first of all detected in the area of at least one filament of the fluorescent lamp. The determined temperature is then compared with a predetermined critical temperature, and the power supply to the filament is interrupted by a ballast if the determined temperature reaches or exceeds the predetermined critical temperature. | 12-17-2009 |
Steven Frucht, New York, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090137565 | Method for treatment of movement disorders - The invention is directed to methods of treating movement disorders by administering an effective amount of the compound of formula (I) to patients in need thereof. More particularly, the invention is directed to a method for treating myoclonus including administering to a patient a compound of formula (I), wherein the myoclonus is not alcohol responsive essential myoclonus with dystonia. In some embodiments, the myoclonus is posthypoxic myoclonus. The invention is also directed to a method for treating dystonia, essential tremor cerebellar tremor, a tic, or chorea, including administering to a patient a compound of formula (I). | 05-28-2009 |